Qualigen Therapeutics, Inc.

F3-8-60 suppresses RAS mitogenic signaling pathways in Panc1 cells (KRAS12D)

F3-8-60 suppresses RAS mitogenic signaling pathways in Panc1 cells (KRAS12D)

Format

PNG

Source

Qualigen Therapeutics, Inc.

Téléchargements